NEWPORT NEWS, Va., Dec. 15, 2025 /PRNewswire/ — Dilon Applied sciences, a number one supplier of medical units, has gained FDA approval for its MarginProbe® 2 system and is saying its launch within the U.S. That is the next-generation system for real-time intraoperative margin evaluation in breast most cancers surgical procedure. MarginProbe® 2 is designed to assist surgeons obtain larger precision throughout breast-conserving surgical procedures, lowering the necessity for extra procedures and bettering affected person outcomes.
This builds on the confirmed success of the unique MarginProbe®, the one real-time margin evaluation system in the marketplace with a sturdy library of printed knowledge proven to scale back re-excisions by over 54% on common. The brand new system, developed by Dilon’s crew in Israel, supplies elevated sensitivity on all tumors with an array of miniaturized sensors, enhanced detection algorithms, and seamless integration into the working room workflow, permitting surgeons to make important selections with confidence whereas within the OR.
The sensitivity has elevated to over 76% on all specimens which was reported out within the pivotal examine performed within the U.S. Surgeons can now choose an choice to have MarginProbe® detect most cancers by selecting DCIS (ductal carcinoma in-situ) or Invasive. DCIS accounts for 31% of re-excisions in ladies ages 18-64 and 24% in ladies over the age of 65 in line with a current examine printed within the Annals of Surgical Oncology1. The workflow of MarginProbe® is appropriate with any hospital setting and the straightforward to make use of interface is maintained on this subsequent technology.
“MarginProbe® 2 is a game-changer for breast surgical procedure,” stated George Makhoul, CEO of Dilon Applied sciences. “By offering surgeons with fast, dependable margin data, we’re serving to scale back re-excision charges and enhance the general surgical expertise for each sufferers and healthcare suppliers. Nobody desires to have to come back again for a reoperation. Our purpose is to ensure surgeons can get it the primary time.”
MarginProbe® customers proceed to focus on the affect of the expertise:
- “Inside 3-5 minutes I’ve fast, binary outcomes of optimistic or unfavourable margins on my specimen. I can decide for my affected person in actual time which has helped me preserve my 4.6% re-excision price,” in line with Dr. Vincent Reid from Mercy Hospital in Cedar Rapids, IA.
- “MarginProbe® is easy to make use of within the OR and provides minimal time to the process. The system supplies outcomes which are straightforward to interpret and apply in actual time for intraoperative lumpectomy margin evaluation. The educational curve is brief, and the MarginProbe® may be utilized in any follow setting to assist breast conserving surgical procedure.,” acknowledged Dr. Freya Schnabel from NYU Langone.
- Dr. Jaime Alberty from NYC Well being and Hospitals System has lauded, “The adjustments made on this system to enhance the sensitivity with out sacrificing specificity are spectacular. DCIS is a significant ache level in our re-excisions and something we will reliably use to scale back that might be used.”
The U.S. launch of MarginProbe® 2 displays Dilon’s dedication to advancing patient-first applied sciences that assist extra exact care and improved medical outcomes. Dilon’s sturdy industrial crew might be showcasing the expertise nationwide. Hospitals and breast surgeons can go to www.dilon.com for extra data.
About Dilon Applied sciences
Dilon Applied sciences Inc., a medical system producer, based mostly in Newport Information, Virginia, strives to enhance the standard of life by offering a variety of modern medical options that profit sufferers world wide. Dilon has a robust medical system portfolio; HEMOBLAST Bellows®, the one mixture powdered hemostat that comprises collagen, thrombin and chondroitin sulfate; the Navigator™ 2.0 System, a trusted model and world-renowned surgical gamma probe for radio-guided lymphatic mapping and tumor localization, the MarginProbe®, a groundbreaking expertise for correct margin evaluation in breast most cancers surgical procedure, and the CoPilot, an modern, transportable, and straightforward to make use of video laryngoscope. For extra data, go to www.dilon.com.
1. Kim Y, Ganduglia-Cazaban C, Tamirisa N, Lucci A, Krause TM. Up to date Evaluation of Reexcision and Conversion to Mastectomy Charges and Related Healthcare Prices for Girls Present process Breast-Conserving Surgical procedure. Ann Surg Oncol. 2024 Feb 6. doi: 10.1245/s10434-024-14902-z.
SOURCE Dilon Applied sciences
Leave a Reply